drugset / Trial / NCT00274352
A Study of Adalimumab to Treat Sarcoidosis of the Skin
Phase 2
Completed
16 enrolled
Pariser, Robert J., M.D.
Abbott · collabVirginia Clinical Research, Inc. · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine if adalimumab is an effective for the skin manifestations of sarcoidosis.
Timeline
- Start
- 2006-09
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adalimumab | Monoclonal antibody | 40 mg | Subcutaneous |